Rosario Sebastiano Spada

Rosario Sebastiano Spada

Auto-generated profile, based on publicly available information

Rosario Sebastiano Spada

Oasi Institute for Research on Mental Retardation and Brain Aging (IRCCS), Troina, Italy

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2007 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
RFRaffaele Ferri
Raffaele Ferri
BLB. Lanuzza
B. Lanuzza
FCF. I. I. Cosentino
F. I. I. Cosentino
III. Iero
I. Iero
MTM. Tripodi
M. Tripodi
MZM. Zucconi
M. Zucconi

1 December 2008 in Sleep Medicine
Verified
Journal Article
Closed access
FCFilomena I.I. Cosentino
Filomena I.I. Cosentino
PBPaolo Bosco
Paolo Bosco
VDValeria Drago
Valeria Drago
GPGiuseppina Prestianni
Giuseppina Prestianni
BLBartolo Lanuzza
Bartolo Lanuzza
RFRaffaele Ferri
Raffaele Ferri

1 April 2004 in NeuroReport
Verified
Journal Article
Closed access
GAGuido Anello
Guido Anello
RGRosa-Maria Guéant-Rodríguez
Rosa-Maria Guéant-Rodríguez
PBPaolo Bosco
Paolo Bosco
JGJean-Louis Guéant
Jean-Louis Guéant
ARAntonino Romano
Antonino Romano
RFRaffaele Ferri
Raffaele Ferri
Homocysteine metabolism is influenced by genetic polymorphisms of the methylenetetrahydrofolate reductase (MTHFR 677 C→T and 1298 A→C) and transcobalamin genes (TCN1 776 C→G ). We evaluated the association of homocysteine with Alzheimer's disease (AD) and the influence of related polymorphisms and APOE, in 180 cases and 181 controls from southern Italy. Homocysteine (upper tercile) was associated with AD risk, with an odds ratio of 2.8 (95% confidence interval (CI) 1.54–5.22, p=0.0008), which was increased 2.2- and 2.0-fold by MTHFR 677 T (odds ratio 6.28, 95% CI 2.88–16.20, p < 0.0001) and APOE ε4 (odds ratio: 5.60, 95% CI 1.12–28.05, p=0.0361), respectively. In conclusion, association of homocysteine with AD was aggravated by MTHFR 677 T and APOE ε4 alleles.

1 April 2012 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
FCFilippo Caraci
Filippo Caraci
PBPaolo Bosco
Paolo Bosco
Maria Salvina SignorelliMaria Salvina Signorelli
Maria Salvina Signorelli
RSRosario S. Spada
Rosario S. Spada
FCFilomena I. Cosentino
Filomena I. Cosentino
RFRaffaele Ferri
Raffaele Ferri

1 July 2004 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Open access
PDF file
PBP Bosco
P Bosco
RGR-M Guéant-Rodríguez
R-M Guéant-Rodríguez
GAG Anello
G Anello
ARA Romano
A Romano
BNB Namour
B Namour
JGJ-L Guéant
J-L Guéant
Background: Genetic polymorphisms of APO-E, homocysteine, and the IL-1 gene cluster (IL-1A, IL-1B, receptor antagonist IL-1RN) are associated with sporadic Alzheimer’s disease and may involve interdependent pathways of neuronal toxicity. Objective: To determine whether these polymorphisms and the genetic determinants of homocysteine (methylenetetrahydrofolate reductase, MTHFR; methionine synthase, MTR; transcobalamin, TC) are associated with an increased risk of severe dementia in Alzheimer’s disease. Methods: 152 patients with Alzheimer’s disease and 136 controls were studied. The association of occurrence and dementia severity (Reisberg score <6 and ⩾6) of Alzheimer’s disease with APO-E, IL-1A, IL-1B, IL-1RN, MTHFR677 C→T and 1298A→C, MTR 2756 A→G, and TC 776 C→G polymorphisms was evaluated by multivariate logistic regression analysis after adjustment for age, sex, and age of onset of Alzheimer’s disease. Results:IL-1A TT and IL-1B CT/TT associated genotypes were at risk of Alzheimer’s disease (odds ratio 4.80 (95% confidence interval, 1.32 to 17.40), p = 0.017); the MTR 2756 AA genotype was at risk of severe dementia (OR 2.97 (1.23 to 7.21), p = 0.016); IL-1 RN*2 was protective (OR 0.28, (0.11 to 0.69), p = 0.006). Allele ϵ4 of the APO-E and IL-1B CC genotypes increased the risk of severe Alzheimer’s disease associated with the MTR 2756 AA genotype by 3.3-fold and 1.5-fold, respectively. Conclusions: Distinct determinants of the IL-1 gene cluster are related to the generation and progression of Alzheimer’s disease. MTR only influences progression of the disease, which may be enhanced by carriage of allele ϵ4 of APO-E.

1 August 2013 in International Journal of Cardiology
Verified
Journal Article
Closed access
RRR.M. Guéant Rodriguez
R.M. Guéant Rodriguez
RSR. Spada
R. Spada
SPS. Pooya
S. Pooya
EJE. Jeannesson
E. Jeannesson
MGM.A. Moreno Garcia
M.A. Moreno Garcia
JGJ.L. Guéant
J.L. Guéant